10 сентября 2020
MRNA $AZN у астры проблемы обросли подробностями:
The participant who triggered a global shutdown of AstraZeneca’s Phase 3 Covid-19 vaccine trials was a woman in the United Kingdom who experienced neurological symptoms consistent with a rare but serious spinal inflammatory disorder called transverse myelitis. ...also confirmed that the clinical trial was halted once previously in July after a participant experienced neurological symptoms. Upon further examination, that participant was diagnosed with multiple sclerosis, deemed to be unrelated to the Covid-19 vaccine treatment, he said.
Вызвал поперечный миелит у пациентки. В июле также была остановка из-за склероза у пациента,но тогда списали на причины,не связанные с препаратом